| Pharmaceutical Information |
| Drug Name |
Cefprozil |
| Drug ID |
BADD_D00397 |
| Description |
Cefprozil is a cephalosporin antibiotic that is commonly employed to treat a variety of bacterial infections, including those of the ear and skin, bronchitis, and others. |
| Indications and Usage |
For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph |
| Marketing Status |
approved |
| ATC Code |
J01DC10 |
| DrugBank ID |
DB01150
|
| KEGG ID |
D00261; D07651
|
| MeSH ID |
C052018
|
| PubChem ID |
5281006
|
| TTD Drug ID |
D0YX4S
|
| NDC Product Code |
82608-009; 65862-100; 57297-400; 16714-399; 68180-403; 65862-069; 16714-397; 50090-1710; 57237-034; 68180-401; 68180-404; 57237-035; 0093-1077; 57237-036; 61788-4000; 65862-068; 65862-378; 0093-1078; 68180-402; 16714-398; 16714-396; 65862-099; 67296-1180; 57237-037 |
| UNII |
4W0459ZA4V
|
| Synonyms |
cefprozil | BMY 28100 | BMY-28100 | 7-(2-amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | cefprozil monohydrate | 7-(2-amino-2-(4-hydroxyphenyl)acetamido)-3-(propenyl)-3-cephem-4-carboxylic acid monohydrate | Cefzil | Procef | Arzimol | Brisoral |
|
| Chemical Information |
| Molecular Formula |
C18H19N3O5S |
| CAS Registry Number |
92676-86-3 |
| SMILES |
CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
